• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受第二代抗精神病药物治疗的精神分裂症患者代谢综合征的患病率——一项横断面研究。

Prevalence of the metabolic syndrome in schizophrenic patients receiving second-generation antipsychotic agents--a cross-sectional study.

作者信息

Kagal Urmila A, Torgal Shashikant S, Patil Nanasaheb M, Malleshappa Anil

机构信息

Department of Pharmacology, KLE University's, Jawaharlal Nehru Medical College, Nehrunagar, Belgaum, Karnataka, India.

出版信息

J Pharm Pract. 2012 Jun;25(3):368-73. doi: 10.1177/0897190012442220. Epub 2012 May 2.

DOI:10.1177/0897190012442220
PMID:22551560
Abstract

OBJECTIVE

The present study was taken up to assess the prevalence of the metabolic syndrome in schizophrenic patients receiving second-generation antipsychotic agents and to determine the most sensitive and specific clinical parameters used for screening of metabolic syndrome in these patients.

MATERIALS AND METHODS

The present study was taken up in a tertiary care hospital. Eighty patients diagnosed with schizophrenia and receiving a single second-generation antipsychotic for 3 months or more were enrolled in the study after obtaining written informed consent. Patients were screened for metabolic syndrome using American Heart Association and National, Heart, Lung and Blood Institute (AHA NHLBI)-modified National Cholesterol Education Program, Adult Treatment Panel III (NCEP ATP III) criteria.

RESULTS

Prevalence of metabolic syndrome was found to be 35%. The clinical parameter with highest sensitivity for screening of metabolic syndrome is low-serum high-density lipoprotein cholesterol with a sensitivity of 89.28%. Elevated fasting blood glucose and increased waist circumference were found to have highest and equal specificity of 90.38%.

CONCLUSION

There is a high prevalence of the metabolic syndrome in patients with schizophrenic patients receiving second-generation antipsychotic agents. Increasing awareness of this fact among psychiatrists will help to prevent, detect, and treat this condition that is associated with considerable morbidity and mortality.

摘要

目的

开展本研究以评估接受第二代抗精神病药物治疗的精神分裂症患者代谢综合征的患病率,并确定用于筛查这些患者代谢综合征的最敏感和特异的临床参数。

材料与方法

本研究在一家三级护理医院进行。在获得书面知情同意后,80例被诊断为精神分裂症且接受单一第二代抗精神病药物治疗3个月或更长时间的患者被纳入研究。使用美国心脏协会和美国国立心肺血液研究所(AHA NHLBI)修订的美国国家胆固醇教育计划成人治疗小组第三次报告(NCEP ATP III)标准对患者进行代谢综合征筛查。

结果

发现代谢综合征的患病率为35%。筛查代谢综合征敏感性最高的临床参数是血清高密度脂蛋白胆固醇降低,敏感性为89.28%。空腹血糖升高和腰围增加的特异性最高且相等,均为90.38%。

结论

接受第二代抗精神病药物治疗的精神分裂症患者中代谢综合征的患病率较高。精神科医生提高对这一事实的认识将有助于预防、检测和治疗这种与相当高的发病率和死亡率相关的疾病。

相似文献

1
Prevalence of the metabolic syndrome in schizophrenic patients receiving second-generation antipsychotic agents--a cross-sectional study.接受第二代抗精神病药物治疗的精神分裂症患者代谢综合征的患病率——一项横断面研究。
J Pharm Pract. 2012 Jun;25(3):368-73. doi: 10.1177/0897190012442220. Epub 2012 May 2.
2
Metabolic syndrome and antipsychotic monotherapy treatment among schizophrenia patients in Malaysia.马来西亚精神分裂症患者的代谢综合征与抗精神病药单药治疗。
Prev Med. 2013;57 Suppl:S50-3. doi: 10.1016/j.ypmed.2013.01.005. Epub 2013 Jan 18.
3
Atypical antipsychotic drugs, schizophrenia, and metabolic syndrome in non-Euro-American societies.非欧美社会中的非典型抗精神病药物、精神分裂症与代谢综合征
Clin Neuropharmacol. 2012 May-Jun;35(3):141-7. doi: 10.1097/WNF.0b013e31824d5288.
4
Metabolic syndrome and cardiovascular risk among patients with schizophrenia receiving antipsychotics in Malaysia.马来西亚接受抗精神病药物治疗的精神分裂症患者的代谢综合征与心血管风险。
Singapore Med J. 2012 Dec;53(12):801-7.
5
The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophrenia.氯氮平治疗的韩国精神分裂症患者中代谢综合征的患病率及其与丙氨酸氨基转移酶的关系。
Int Clin Psychopharmacol. 2013 Mar;28(2):71-9. doi: 10.1097/YIC.0b013e32835b99bd.
6
[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].[制定重症精神疾病患者身体健康检查指南]
Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9.
7
The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs.METEOR 研究:精神分裂症患者代谢紊乱的频率。关注第一代和第二代抗精神病药物以及风险水平。
Int Clin Psychopharmacol. 2011 Nov;26(6):291-302. doi: 10.1097/YIC.0b013e32834a5bf6.
8
Prevalence and predictors of metabolic syndrome among patients attending an outpatient clozapine clinic in Australia.澳大利亚一家氯氮平门诊患者中代谢综合征的患病率及预测因素。
Arch Psychiatr Nurs. 2009 Jun;23(3):261-8. doi: 10.1016/j.apnu.2008.06.007. Epub 2009 Jan 15.
9
Prevalence of metabolic syndrome in reproductive-aged polycystic ovary syndrome Thai women.泰国育龄期多囊卵巢综合征女性代谢综合征的患病率
J Med Assoc Thai. 2010 Jun;93(6):653-60.
10
Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.根据美国国家胆固醇教育计划成人治疗组第三次报告(NCEP-ATP III)和国际糖尿病联盟(IDF)的定义,血液透析患者代谢综合征的发生率
Ren Fail. 2009;31(3):221-8. doi: 10.1080/08860220802669883.

引用本文的文献

1
Prevalence and predictors of metabolic syndrome among psychiatric patients receiving antipsychotic treatment in Africa: a systematic review and meta-analysis.非洲接受抗精神病药物治疗的精神科患者中代谢综合征的患病率及预测因素:一项系统评价和荟萃分析。
BMC Psychiatry. 2025 Apr 29;25(1):433. doi: 10.1186/s12888-025-06894-1.
2
Antipsychotics and Medical Comorbidity: A Retrospective Study in an Urban Outpatient Psychiatry Clinic.抗精神病药物与躯体共病:一项针对城市门诊精神科诊所的回顾性研究。
Community Ment Health J. 2023 May;59(4):641-653. doi: 10.1007/s10597-022-01045-2. Epub 2022 Nov 10.
3
Effect of Psychotropic Medications on Hammertoe Reconstruction Outcomes.
精神药物对槌状趾重建结果的影响。
Foot Ankle Orthop. 2020 Aug 25;5(3):2473011420944133. doi: 10.1177/2473011420944133. eCollection 2020 Jul.
4
Risk Factors of Metabolic Syndrome Among Patients Receiving Antipsychotics: A Retrospective Study.接受抗精神病药物治疗患者代谢综合征的危险因素:一项回顾性研究。
Community Ment Health J. 2020 May;56(4):760-770. doi: 10.1007/s10597-019-00537-y. Epub 2019 Dec 28.
5
Low prevalence of lipid metabolism abnormalities in APOE ε2-genotype and male patients 60 years or older with schizophrenia.载脂蛋白 E ε2 基因型和 60 岁及以上男性精神分裂症患者中脂代谢异常的低患病率。
BMC Psychiatry. 2017 Dec 12;17(1):399. doi: 10.1186/s12888-017-1530-9.
6
Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review.第一代和第二代抗精神病药物的安全性、耐受性及相关风险:最新临床综述
Ther Clin Risk Manag. 2017 Jun 29;13:757-777. doi: 10.2147/TCRM.S117321. eCollection 2017.
7
Body mass index and metabolic parameters in patients with schizophrenia during long-term treatment with paliperidone palmitate.精神分裂症患者长期使用棕榈酸帕利哌酮治疗后的体重指数和代谢参数。
BMC Psychiatry. 2014 Feb 22;14:52. doi: 10.1186/1471-244X-14-52.
8
Metabolic syndrome in schizophrenia.精神分裂症中的代谢综合征
Indian J Psychol Med. 2013 Jul;35(3):227-40. doi: 10.4103/0253-7176.119471.
9
A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls.一项针对初发和反复发作精神分裂症患者与一般人群对照的药物未治疗、首发和反复发作患者的代谢异常的荟萃分析。
World Psychiatry. 2013 Oct;12(3):240-50. doi: 10.1002/wps.20069.
10
Do psychiatric comorbidities influence inpatient death, adverse events, and discharge after lower extremity fractures?精神科合并症是否会影响下肢骨折患者的住院死亡、不良事件和出院?
Clin Orthop Relat Res. 2013 Oct;471(10):3336-48. doi: 10.1007/s11999-013-3138-9. Epub 2013 Jun 30.